MARKSANS

Pharmaceuticals

Marksans Pharma Ltd.

NSE: MARKSANSBSE: 524404ISIN: INE750C01026

₹246.30

+0.20 · +0.08%

As of 24 Jul 2026

Open

₹244.90

High

₹248.60

Low

₹242.40

Prev Close

₹246.10

52W High

₹281.60

52W Low

₹155.00

Volume

8.07 L

Mkt Cap

₹11,199 Cr

Fundamentals

Valuation & profitability

Market Cap

₹11,199 Cr

P/E Ratio

27.1

EPS (TTM)

₹9.09

Book Value

₹45.60

Dividend Yield

0.27%

ROCE

20.6%

ROE

16.5%

Sales Growth

17%

Face Value

₹1.00

Key highlights

Auto-generated from live data

Trades at a P/E of 27.1, with a return on equity (ROE) of 16.5%.
MARKSANS is trading above 2 of 5 of its key moving averages (10/20/50/100/200-DMA) — a bearish technical setup.
Year-to-date it is up 37.49%, and up 27.32% over the past year.
At ₹246.30 it sits about 72% of the way up its 52-week range (₹155.00–₹281.60).
Offers a dividend yield of 0.27%.
Market capitalisation stands at ₹11,199 Cr.

Price chart

Daily candles + volume · SMA 20 / 50 / 200 · stored OHLC

Shareholding pattern

Shareholding data syncs daily.

Performance

Stock returns vs Nifty 50

10D

-8.07%

Nifty -0.64%

20D

-4.43%

Nifty -1.72%

50D

+3.38%

Nifty +2.68%

100D

+39.79%

Nifty -1.14%

200D

+37.33%

Nifty -8.93%

YTD

+37.49%

Nifty -8.59%

52W

+27.32%

Nifty -7.86%

Moving averages

Simple moving averages vs current price

2/5 above · Bearish

SMA 10-Day

₹261.92Below

SMA 20-Day

₹264.50Below

SMA 50-Day

₹249.93Below

SMA 100-Day

₹213.60Above

SMA 200-Day

₹197.08Above

Price ranges

Where the price sits in each window

10-Day range₹246.30

₹239.65₹281.40

20-Day range₹246.30

₹239.65₹281.60

50-Day range₹246.30

₹197.41₹281.60

200-Day range₹246.30

₹155.00₹281.60

YTD range₹246.30

₹155.00₹281.60

52-Week range₹246.30

₹155.00₹281.60

Technical signals

Unfilled gaps acting as support / resistance

Unfilled Gap Down On 22 Jul, 2026 : 249.00 ~ 253.05RESISTANCE

Unfilled Gap Up On 08 Apr, 2026 : 172.00 ~ 171.30SUPPORT

Unfilled Gap Up On 15 Nov, 2022 : 52.50 ~ 51.45SUPPORT

Unfilled Gap Up On 05 Jul, 2022 : 47.05 ~ 44.35SUPPORT

Unfilled Gap Up On 15 Jun, 2020 : 31.05 ~ 30.65SUPPORT

Unfilled Gap Up On 03 Jun, 2020 : 28.90 ~ 26.30SUPPORT

Unfilled Gap Up On 08 Apr, 2020 : 18.00 ~ 17.75SUPPORT

Unfilled Gap Up On 07 Apr, 2020 : 16.05 ~ 15.50SUPPORT

Annual financials

Revenue, profit & EPS by financial year

Year	Revenue	Net Profit	EPS	NPM
Mar 2023	₹655 Cr	₹103 Cr	₹2.27	15.73%
Mar 2022	₹658 Cr	₹104 Cr	₹2.54	15.81%
Mar 2021	₹1,376 Cr	₹239 Cr	₹5.83	17.37%
Mar 2021	₹1,376 Cr	₹239 Cr	₹5.83	17.37%
Mar 2020	₹1,134 Cr	₹117 Cr	₹2.86	10.32%
Mar 2020	₹1,134 Cr	₹117 Cr	₹2.86	10.32%
Mar 2019	₹1,000 Cr	₹76 Cr	₹1.87	7.6%
Mar 2019	₹1,000 Cr	₹76 Cr	₹1.87	7.6%
Mar 2018	₹913 Cr	₹33 Cr	₹0.80	3.61%
Mar 2017	₹767 Cr	₹9 Cr	₹0.22	1.17%
Mar 2016	₹893 Cr	₹79 Cr	₹1.89	8.85%
Mar 2015	₹797 Cr	₹109 Cr	₹2.64	13.68%

Peer comparison

Other companies in Pharmaceuticals

Company	P/E	Book Value	Sales Growth
SUNPHARMA SUN PHARMACEUTICAL INDUSTRIES LTD.	39.1	₹98.33	10.1%
MOREPENLAB MOREPEN LABORATORIES LTD.	20.81	₹6.43	16.6%
NEULANDLAB NEULAND LABORATORIES LTD.	23.48	₹542.16	9.35%
GUFICBIO Gufic BioSciences Ltd.	24.16	₹10.85	20.41%
DIVISLAB DIVI'S LABORATORIES LTD.	41.01	₹266.77	9.47%
DRREDDY DR.REDDY'S LABORATORIES LTD.	19.73	₹852.69	1.07%
RPGLIFE RPG LIFE SCIENCES LTD.	17.14	₹105.02	5.73%
GLAND Gland Pharma Ltd	53.6	₹242.00	—
ZYDUSLIFE Zydus Lifesciences Ltd	8.23	₹166.00	5%
SMSPHARMA SMS PHARMACEUTICALS LTD.	9.58	₹42.07	-8.73%
CIPLA CIPLA LTD.	15.36	₹209.71	0.7%

Dividend history

Per share, by ex-date

Ex-Date: 07 Jun 2023₹0.00

Ex-Date: 19 Aug 2022₹0.25

Ex-Date: 15 Sept 2021₹0.25

Ex-Date: 22 Sept 2020₹0.10

Ex-Date: 19 Sept 2019₹0.05

Ex-Date: 19 Sept 2018₹0.05

Ex-Date: 19 Sept 2017₹0.05

Ex-Date: 22 Sept 2016₹0.12

Ex-Date: 23 Sept 2015₹0.12

Ex-Date: 18 Sept 2014₹0.10

Ex-Date: 05 Sept 2001₹0.00

Bulk & block deals

Recent large transactions

Date	Client	Type	Qty	Price
04 Jun 2014	BARNACLE LLC	SALE	84,00,241	₹20.36
31 Aug 2009	JMP SECURITIES PVT LTD	PURCHASE	32,17,002	₹6.62
31 Aug 2009	JMP SECURITIES PVT LTD	SALE	30,18,014	₹6.60
16 Jun 2009	ANGEL INFIN PRIVATE LIMITED	PURCHASE	18,40,055	₹5.47
16 Jun 2009	ANGEL INFIN PRIVATE LIMITED	SALE	18,40,065	₹5.67
18 Nov 2008	ANJALI CHAWLA	PURCHASE	19,95,747	₹6.03
18 Nov 2008	KABUL CHAWLA	SALE	19,95,747	₹6.03
02 Sept 2008	XITIJ INVESTMENTS	SALE	33,25,000	₹18.25
23 May 2008	SHRADHA TRADELINKS PVT LTD	PURCHASE	18,00,000	₹21.15
22 Feb 2008	DHWANI M DOSHI	PURCHASE	1,86,471	₹235.35
19 Dec 2007	UTI INDIA TECHNOLOGY VENTURE UNIT SCHEME	SALE	3,52,215	₹228.30
01 Nov 2007	MARK GRACIAS SALDANHA	PURCHASE	4,30,000	₹120.00

Explore more

Pharmaceuticals sector

Sector peers & index performance

MARKSANS news & filings

Latest corporate announcements

Top Gainers

Biggest NSE gainers today

Top Losers

Biggest NSE losers today

IPO Calendar

Open & upcoming IPOs

Stock Screener

Find more stocks like this

Fundamentals, financials & technicals sourced from niftytrader.in, cached and refreshed periodically.